MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Caution in handling by female operatives. Avoid handling leaking capsules. Should not be handled by pregnant women and women of childbearing potential.

Provenance

This compatibility recommendation is derived from Combodart 0.5mg/0.4mg capsules (GlaxoSmithKline UK Ltd).

Stability Notes

Store in an airtight container.

Provenance

This compatibility recommendation is derived from Competact 15mg/850mg tablets (Neon Healthcare Ltd).

Stability Notes

Store in an airtight container.

Provenance

This compatibility recommendation is derived from Competact 15mg/850mg tablets (Neon Healthcare Ltd).

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

This compatibility recommendation is derived from Concerta XL 18mg tablets (Janssen-Cilag Ltd).

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

This compatibility recommendation is derived from Concerta XL 18mg tablets (Janssen-Cilag Ltd).

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

This compatibility recommendation is derived from Concerta XL 18mg tablets (Janssen-Cilag Ltd).

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

Compatibility recommendation derived from Concerta XL 27mg tablets (Janssen-Cilag Ltd)

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

Compatibility recommendation derived from Concerta XL 27mg tablets (Janssen-Cilag Ltd)

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

Compatibility recommendation derived from Concerta XL 27mg tablets (Janssen-Cilag Ltd)

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

Compatibility recommendation derived from Concerta XL 36mg tablets (Janssen-Cilag Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.